from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1512/epiA

LFCtreatmentdescriptionclass of inhibitor

-2.419

Amikacinug/mL Amikacintranslation

-1.148

Cap5-10ug/mL Capreomycintranslation

-1.517

Rox10-50 ug/mL Roxithromycintranslation

-0.119

SM2-5 ug/mL Streptomycintranslation

-1.833

Tet5-10 ug/mL Tetracyclinetranslation

-1.006

Rif0.2-5ug/mL Rifampicintranscription

-0.259

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.126

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.183

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.186

Clofazimine10-13 ug/mL Clofaziminerespiration

0.875

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.096

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.214

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.758

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.328

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.331

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.287

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.867

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.525

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.403

KCN5-20 ug/mL Potassium cyaniderespiration

0.293

NaN30.2-2 mM Sodium aziderespiration

-0.988

Nigericin50 uM Nigericinrespiration

-1.040

TRC10-150 ug/mL Triclosanrespiration

0.547

TRZ10-25 ug/mL Thioridazinerespiration

-0.383

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.498

menadione6-10 ug/mL Menadionerespiration

0.232

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.346

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.717

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.642

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.946

NRP_1Non-replicating persistence stage 1dosRassociated

0.335

Amp0.2mg/mL AmpicillincellWall

0.306

Cephalexin20-100 ug/mL CephalexincellWall

0.378

Cerulenin0.32-5 ug/mL CerulenincellWall

0.316

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.149

EMB10-20 ug/mL EthambutolcellWall

0.014

Eta12-40 ug/mL EthionamidecellWall

0.310

INH0.2-0.4 ug/mL IsoniazidcellWall

0.190

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.313

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.488

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.812

BZA0.12 mg/mL BenzamidearomaticAmides

-0.414

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.089

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.469

H2O24 mM hydrogen peroxideDNAdamaging

-0.155

Levo10 ug/mL LevofloxacinDNAdamaging

0.168

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.138

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.156

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.518

UVUV-irradiationDNAdamaging

0.553

ARP41-4 ug/mL Antitubercular compound ARP4?

0.231

Antimycin12.5-50 ug/mL Antimycin A?

-0.571

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.253

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.042

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.217

PA8240.2-2 ug/mL PA-824?

-0.000

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.399

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.588

Verapamil50 uM Verapamil?

-0.621

mercaptoethanol2 mM 2-Mercaptoethanol?

0.758

methoxatin10-20 ug/mL Methoxatin?